Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
Addison's disease
anemia
chelation therapy
cortisol, low
endocarditis, infectious
fatigue
fingernails, abnormal
gum discoloration
gum disease
heralding manifestation
hyperpigmentation of skin
inattention
irritability
lead and the nervous system
lead line, gingival
lead poisoning
memory, impairment of
misdiagnosis
mood change
nausea and vomiting
neuroendocrinology
occupational neurologic disorders
occupational neuropathies
pain, abdominal
personality change
skin, darkening of
skin, discoloration
tongue, black
tongue, discoloration
tongue, hyperpigmentation
treatment of neurologic disorder
weight loss
wrist drop
Showing articles 650 to 700 of 1070 << Previous Next >>

Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation:A Meta-Analysis
Ann Int Med 131:492-501,537, Hart,R.G.,et al, 1999

Antiplatelet Therapy:Views from the Experts
Neurol 53:S32-S37, Easton,J.D.,et al, 1999

Behcet's Disease
NEJM 341:1284-1291, Sakane,T.,et al, 1999

Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999

Is Cholesterol a Risk Factor for Stroke? No
Arch Neurol 56:1521-1524, Landau,W.M., 1999

Is Cholesterol a Risk Factor for Stroke? Yes
Arch Neurol 56:1518-1520,1524, Demchuk,A.M.,et al, 1999

Clinicopath Conf,Guillain-Barre Syndrome, Campylobacter Jejuni Enteritis,Case 39-1999
NEJM 341:1996-2003, , 1999

Frequency of Major Complications of Aspirin,Warfarin,and Intravenous Heparin for Secondary Stroke Prevention,A Population-Based Study
Ann Int Med 130:14-22, Petty,G.W.,et al, 1999

Randomized,Placebo-Controlled Trial of Anticoagulant Treatment with Low-Molecular-Weight Heparin for Cerebral Sinus Thrombosis
Stroke 30:484-488,481, de Bruijn,S.F.T.M.,et al, 1999

Anticoagulation Therapy in Pediatric Patients with Sinovenous Thrombosis,A Cohort Study
Arch Neurol 55:1533-1537, deVeber,G.,et al, 1998

Cerebrovascular Disease in African Americans
Stroke 29:2656-2664, Gorelick,P. B., 1998

Aspirin and Risk of Hemorrhagic Stroke
JAMA 280:1930-1935,1949, He,J.,et al, 1998

Warfarin Use Following Ischemic Stroke Among Medicare Patients with Atrial Fibrillation
Arch Int Med 158:2093-2100, Brass,L.A.,et al, 1998

Mobile Aortic Atheroma & Systemic Emboli:Efficacy of Anticoag & Influence of Plaque Morphol on Recurr Stroke
J Am Coll Cardiol 31:134-138, Dressler,F.A.,et al, 1998

The APOE-e4 Allele and the Risk of Alzheimer Disease Among AFrican Americans, Whites and Hispanics
JAMA 279:751-755, 7881998., Tang,M.,et al, 1998

Prader-Willi and Angelman Syndromes
Medicine 77:140-151, Cassidy,S.B.&Schwartz,S., 1998

The Antiplatelet Effects of Ticlopidine and Clopidogrel
Ann Int Med 129:394-405, Sharis,P.J.,et al, 1998

Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Neurol 51:674-681, Hart,R.G.,et al, 1998

Stroke Prevention in Patients with Nonvascular Atrial Fibrillation
Qual Stds Subcom AAN, Neurol 51:671-6731998., , 1998

Dilemma of Discontin of Anticoag Therapy for Pts with Intracran Hem & Mech Heart Valves
Neurosurg 42:769-773, Eelco,F.M.,et al, 1998

Stroke Patterns of Internal Carotid Artery Dissection in 40 Patients
Stroke 29:2646-2648, Lucas,C.,et al, 1998

Optic Neuritis in African Americans
Arch Neurol 55:186-192, Phillips,P.H.,et al, 1998

Thrombotic Thrombocytopenic Purpura Assoc with Ticlopidine, Review of 10 Cases
Ann Int Med 128:541-544, Bennett,C.L.,et al, 1998

Different Predictors of Neurolgoical Worsening in Different Causes of Stroke
Arch Neurol 55:481-486, Yamamoto,H.,et al, 1998

Prognosis of Patients with Symptomatic Vertebral or Basilar Artery Stenosis
WASID Study Group, Stroke 29:1389-13921998., , 1998

Aspirin Use and Incident Stroke in the Cardiovascular Health Study
Stroke 29:887-894, 8851998., Kronmal,R.A.,et al, 1998

Clopidogrel for Reduction of Atherosclerotic Events
The Medical Letter 40:59-60, , 1998

Stroke in Children and Sickle-Cell Disease, Baltimore-Washington Cooperative Young Stroke Study
Neurol 51:169-176, Earley,C.J.,et al, 1998

Illicit Drug-Associated Ischemic Stroke in the Baltimore-Washington Young Stroke Study
Neurol 50:1688-1693, Sloan,M.A.,et al, 1998

Cost-Effectiveness of Anticoagulation in Nonrheumatic A Fib in the Primary Prevention of Ischemic Stroke
Stroke 29:1827-1832, Lightowlers,S.&McGuire,A., 1998

Fixed Minidose Warfarin & Aspirin Alone & in Comb vs Adjusted-Dose Warfarin for Stroke Prevent in Atrial Fib
Arch Int Med 158:1513-1521, 14871998., Gullov,A.L.,et al, 1998

Pts with Nonvalvular Fib at Low Risk of Stroke During Trtm with Aspirin
Stroke Prevent in A Fib, SPAF III Cmte for Stroke Prevent, JAMA 279:1273-1277998., , 1998

Low Molecular Wt Heparinoid
ORG 10172 (Danaparoid) , & Outcome After Acute Ischemic Stroke, 10172 Acute Stroke Trtm (TOAST) Inve, t, JAMA 1272,1304,1998., 1998

Cig Smoking as a Determin of High-Grade Carotid Art Sten in Hispanic, Black, & White Pts with Stroke or TIA
Stroke 29:908-912, Mast,H.,et al, 1998

Tardive Dyskinesia:Diagnosis, Pathogenesis, and Management
The Neurologist 4:180-187, Trugman,J.M., 1998

Progression of Alzheimer's Disease in Black and White Patients
Neurol 51:154-158, Fillenbaum,G.G.,et al, 1998

Lack of Relation Between Race and Cognitive Test Performance in Alzheimer's Disease
Neurol 50:1499-1501, Carlson,M.G.,et al, 1998

Cognitive Test Performance Among Nondemented Elderly African Americans and Whites
Neurol 50:1238-1245, Manly,J.J.,et al, 1998

Differences in Medical & Surgical Therapy for Stroke Prevention Between Experts in N. America & Europe
Stroke 29:339-345, Masuhr,F.,et al, 1998

Susac Syndrome
Medicine 77:3-11, Papo,T.,et al, 1998

Effect of HMGcoA Reductase Inhibitors on Stroke, A Meta-Analysis of Controlled Trials
Ann Int Med 128:89-95, Bucher,H.C.,et al, 1998

Differences in Stroke Between White, Hispanic & Native American Patients, Barrow Neuro Inst Stroke Database
Stroke 29:29-33, 21998., Frey,J.L.,et al, 1998

Preventing Stroke Recurrence in Patients with Patent Foramen Ovale: Antithrombotic Therapy, Foramen Closure, or Therapeutic Abstention? A Decision Analytic Perspective
Am Heart J 135:532-541, Nendaz,M.R.,et al, 1998

Comparison of an Anticoagulation Clinic With Usual Medical Care: Anticoagulation Control, Patient Outcomes, and Health Care Costs
Arch Int Med 158:1641-1647, Chiquette,E.,et al, 1998

Diagnosis of Cerebral Venous Thrombosis with Routine Magnetic Resonance: An Update
Eur Neurol 40:179-190, Bianchi,D.,et al, 1998

Tongue Protrusion Dystonia:Treatment with Botulinum Toxin
South Med J 90:522-525, Charles,P.D.,et al, 1997

Does Daily Aspirin Diminish Severity of First-Ever Stroke
Arch Neurol 54:1369-1371, Karepov,V.,et al, 1997

Warfarin Use Among Patients with Atrial Fibrillation
Stroke 28:2382-2389, Brass,L.M.,et al, 1997

A Randomized Trial of Anticoagulants Vs Aspirin After Cerebral Ischemia of Presumed Arterial Origin
SPIRIT Study Group, Ann Neurol 42:857-8651997., , 1997

Ventricular Dysfunction and the Risk of Stroke After Myocardial Infarction
NEJM 336:251-257, Loh,E.,et al, 1997



Showing articles 650 to 700 of 1070 << Previous Next >>